Novartis AG vs Global X Robo Global Robotics & Automation ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Global X Robo Global Robotics & Automation ETF trades at $79.51. The key difference: Novartis AG pays a 3.17% dividend while Global X Robo Global Robotics & Automation ETF pays none, and Novartis AG is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals.
| NVS | ROBO | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $168.62 | $90.34 |
52-Week Low | $113.50 | $61.34 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →